Primidone (Mysoline)

Trade Name : Mysoline

Bausch Health US, LLC

TABLET

Strength 50 mg/1

PRIMIDONE Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Disclaimer

Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of "Fair use"

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Primidone (Mysoline) which is also known as Mysoline and Manufactured by Bausch Health US, LLC. It is available in strength of 50 mg/1 per ml. Read more

Primidone (Mysoline) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Inquire directly from our website and get 5% off on any medicine!

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • Chemical name: 5-ethyldihydro-5-phenyl-4,6 (1H, 5H)-pyrimidinedione. Structural formula:
  • MYSOLINE (primidone) is a white, crystalline, highly stable substance, M.P. 279-284u00b0C. It is poorly soluble in water (60 mg per 100 mL at 37u00b0C) and in most organic solvents. It possesses no acidic properties, in contrast to its barbiturate analog.
  • MYSOLINE 50 mg and 250 mg tablets contain the following inactive ingredients: lactose
  • monohydrate, NF; magnesium stearate, NF; methylcellulose, USP; microcrystalline cellulose, NF;
  • purified water, USP; sodium lauryl sulfate, NF; sodium starch glycolate, NF; and talc, USP.MYSOLINE 250 mg tablets also contain ferric oxide yellow, NF.
  • _______________________________________________________________________________
  • MYSOLINE, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.
  • Primidone is contraindicated in: 1) patients with porphyria and 2) patients who are hypersensitive to phenobarbital (see ).
  • The abrupt withdrawal of antiepileptic medication may precipitate status epilepticus. The therapeutic efficacy of a dosage regimen takes several weeks before it can be assessed.
  • The total daily dosage should not exceed 2 g. Since MYSOLINE therapy generally extends over prolonged periods, a complete blood count and a sequential multiple analysis-12 (SMA-12) test should be made every 6 months.
  • The most frequently occurring early side effects are ataxia and vertigo. These tend to disappear with continued therapy, or with reduction of initial dosage. Occasionally, the following have been reported: nausea, anorexia, vomiting, fatigue, hyperirritability, emotional disturbances, sexual impotency, diplopia, nystagmus, drowsiness, and morbilliform skin eruptions. Granulocytopenia, agranulocytosis, and red-cell hypoplasia and aplasia, have been reported rarely. These and, occasionally, other persistent or severe side effects may necessitate withdrawal of the drug. Megaloblastic anemia may occur as a rare idiosyncrasy to MYSOLINE and to other anticonvulsants. The anemia responds to folic acid without necessity of discontinuing medication.
  • To report SUSPECTED ADVERSE REACTIONS, contact Bausch Health US, LLC at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • No data
  • MYSOLINE Tablets
  • Modified square, flat faced, beveled edge, compressed light yellow color tablet. One face is debossed (impressed) with u201cMYSOLINEu201d and u201c250u201d that are divided by a debossed bisect line. The opposite side is embossed with the letter u201cMu201d, in bottles of 100 (NDC 66490-691-10).
  • Modified square, flat faced, beveled edge, compressed white color tablet. One face is debossed (impressed) with u201cMYSOLINEu201d and u201c50u201d that are divided by a debossed bisect line. The opposite side is embossed with the letter u201cMu201d, in bottles of 100 (NDC 66490-690-10).
  • Storage
  • Store at 20u00b0 to 25u00b0C (68u00b0 to 77u00b0F)n- [see USP Controlled Room Temperature].
  • Dispense in a tight, light-resistant container with a child-resistant closure.
  • Distributed by:
  • Manufactured by:
  • Bausch Health Companies Inc.Steinbach, MB R5G 1Z7, Canada
  • MYSOLINE is a trademark of Bausch Health Companies Inc. or its affiliates.
  • u00a9 2020 Bausch Health Companies Inc. or its affiliates
  • MYSOLINE (My-so-lean)n- (primidone tablets, USP), 50 mg and 250 mg
  • What is the most important information I should know about MYSOLINE?
  • Like other antiepileptic drugs, MYSOLINE may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.
  • Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:
  • Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.
  • How can I watch for early symptoms of suicidal thoughts and actions?
  • What is MYSOLINE?
  • MYSOLINE is a prescription medicine used alone or with other medicines to treat people with:
  • Who should not take MYSOLINE?
  • Do not take MYSOLINE if you:
  • What should I tell my healthcare provider before taking MYSOLINE?
  • Before you take MYSOLINE, tell your healthcare provider if you:
  • Tell your healthcare provider about all the medicines you take,
  • Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist each time you get a new medicine.
  • How should I take MYSOLINE?
  • Take MYSOLINE exactly as prescribed. Your healthcare provider will tell you how much MYSOLINE to take and when to take it.
  • What should I avoid while taking MYSOLINE?
  • What are the possible side effects of MYSOLINE?
  • See u201cWhat is the most important information I should know about MYSOLINE?u201d
  • MYSOLINE may cause other serious side effects including:
  • The most common side effects of MYSOLINE include:
  • These are not all the possible side effects of MYSOLINE. For more information, ask your healthcare provider or pharmacist.
  • Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
  • Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
  • How should I store MYSOLINE?
  • Store MYSOLINE at room temperature between 68u00b0 to 77u00b0F (20u00b0 to 25u00b0C) in a tight, light-resistant container.
  • Keep MYSOLINE and all medicines out of reach of children.
  • General Information about MYSOLINE
  • Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use MYSOLINE for a condition for which it was not prescribed. Do not give MYSOLINE to other people, even if they have the same symptoms that you have. It may harm them.
  • This Medication Guide summarizes the most important information about MYSOLINE. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about MYSOLINE that is written for health professionals.
  • For more information, go to www.bauschhealth.com or call 1-800-321-4576.
  • What are the ingredients in MYSOLINE?
  • Active Ingredient: primidone, USP
  • Inactive Ingredients: lactose monohydrate, NF; magnesium stearate, NF;
  • methylcellulose, USP; microcrystalline cellulose, NF; purified water, USP; sodium lauryl
  • sulfate, NF; sodium starch glycolate, NF; and talc, USP.
  • MYSOLINE 250 mg tablets also contain ferric oxide yellow, NF.
  • Distributed by:
  • Manufactured by:
  • MYSOLINE is a trademark of Bausch Health Companies Inc. or its affiliates.
  • u00a9 2020 Bausch Health Companies Inc. or its affiliates
  • This Medication Guide has been approved by the U.S. Food and Drug Administration.
  • Rev. 07/2020
  • NDC
  • Rx Only
  • Mysolinen
  • 250 mg
  • 100 Tablets
  • Each tabletcontains 250 mgof primidone, USP
  • PHARMACIST: Dispense the accompanyingn- Medication Guide to each patient.
  • BAUSCH Health
  • NDC
  • Rx Only
  • Mysolinen
  • 50 mgn- 100 Tablets
  • Each tabletcontains 50 mgof primidone, USP
  • PHARMACIST: Dispense the accompanyingn- Medication Guide to each patient.
  • BAUSCH Health

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64020 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71247 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51046 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13296 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2024 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.